Practice areas

Cross-border dispute resolution; Cross-border investigations, government enforcement and compliance; Cross-border investment and international trade; Capital markets and M&A

Introduction

Ray Liu is a global partner and the managing partner of Dorsey’s Beijing office, qualified to practise in the State of New York and achieved PRC legal qualification and securities practice qualification.

Liu concentrates on high-stakes cross-border dispute resolution, US litigation, international and foreign-related arbitration, cross-border investigations (government or criminal) and compliance matters. His practice areas also include cross-border investment and international trade, general corporate and M&A, capital markets, foreign direct investment, intellectual property rights and trade secrets, cybersecurity and data privacy in a wide variety of sectors including banking and finance, insurance, asset management, TMT, new energy, intelligent manufacturing, medical and bio-tech, pharmaceutical, food and agriculture, chemicals and materials, mining and energy, and infrastructure. Before joining Dorsey, he worked for the legal department at the New York branch of a major Chinese bank in New York City.

Liu has represented a number of high-profile US litigations, international arbitrations, criminal and government investigations, overseas compliance matters, cross-border transactions and negotiation matters, which have earned him great praise and deep trust from his various clients, from central government-owned and state-owned enterprises, unicorn and public companies, to prestigious multinational and high-profile individuals. His recent select representations include those of (1) a major creditor in the chapter 11 US bankruptcy case filed by Jia Yueting, (2) the major international Chinese banks in high-profile anti-money laundering and counter-terrorist financing cases, (3) managing and completing one of the largest US e-discovery and document review projects to date in China, (4) a major Chinese international insurance company, and its insured, in numerous major product liability, wrongful death and coverage cases in North America, (5) a Chinese company and its executives in a US securities litigation, and (in the first such case) helping the company and its executives obtain a complete dismissal of the lawsuit, and also collecting damages and legal fees from the plaintiff firm, (6) the leading Chinese academics in filing an amicus brief in the high-profile Vitamin C antitrust litigation case before the US Supreme Court, and (7) a number of notable Chinese TMT corporations in their significant transactions, capital market financings, intellectual property rights, compliance and commercial dispute resolution matters in the US and Europe.

Liu takes an active part in social activities and undertakes the social responsibilities in his capacity as a lawyer. He is frequently invited to attend and deliver keynote speeches at major international investment, economic and legal forums and seminars, and invited to lecture at Chinese bar associations, and in continuing legal education courses in the US. He is also regularly interviewed by the People’s Daily, Global Characters, CGTN, China Business Network and The New York Times newspapers, and invited to comment on US-China legal and economic issues that are widely covered by mainstream media.

Liu graduated from Vanderbilt University Law School, and China University of Political Science and Law (CUPL). He received CUPL’s Outstanding Alumni Award, and is an adjunct tutor of the Master of Laws School and Business School of CUPL and a director of the CUPL International Law School Alumni Association.

Back to China A-List 2022